The 3rd annual meeting of the EMI-TB project was held in Vigo, hosted by Africa Gonzalez-Fernandez and her team.

Several important milestones were acheived, and the meeting was a excellent opportunity to plan for the future as our project enters the next phase of delivery.

A public summary of the meeting will be available soon.

TBVI logo

 

 

 

Dr Rajko Reljic and Dr Mathew Paul attended the annual general meeting of the TBVAC2020 consortium and the symposium ‘TB vaccines and Immunity’ (http://www.tbvi.eu/presentations-tbvi-symposium-tb-vaccines-and-immunity/)  in Les Diablerets, Switzerland, 1-5 February. Dr Reljic presented an update on progress of the EMI-TB project and both were invited to TBVAC2020 Steering Committee meeting to discuss future cooperation between the two consortia. Several lines of cooperation were identified with a joint late stage pre-clinical testing of the most promising vaccine candidates at the later stages of the projects being one of them.

EMI TB 1st Annual Meeting, Kick-off

St George's, University of London

2-3 February 2015

EMI-TB participants February 2015.

EMI-TB got underway in earnest with a two day symposium meeting at the co-ordinating institution, St. George's, in London. There was a open session on day 1, giving a chance for anyone interested in the action to come and hear a range of talks covering scientific and managerial aspects, while day 2 focused on establishing research priorities for the first six months of the project.

Participants can access selected presentations, and the minutes of the meeting, here.

EMI-TB held a successful 2nd annual project meeting in Stockholm, hosted by Martin Rottenberg and Carmen Fernandez.

EMI-TB participants at the 2nd AGM

 EMI-TB braves the snow at the 2nd AGM